Edition:
United States

Apricus Biosciences Inc (APRI.PH)

APRI.PH on Philadelphia Stock Exchange

1.09USD
27 Apr 2017
Change (% chg)

-- (--)
Prev Close
$1.09
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,583
52-wk High
$5.71
52-wk Low
$1.09

Select another date:

Fri, Apr 21 2017

CORRECTED-BRIEF-Apricus Biosciences sees offering of up to 5 mln units (April 20)

* Now sees offering of up to 5 million units consisting of one share of common stock and warrant

BRIEF-Apricus Biosciences files for offering of up to $6.0 mln of units

* Files for offering of up to $6.0 million of units, consisting of one share of common stock,warrant to purchase 0.75 of common share Source text for Eikon: Further company coverage:

BRIEF-Apricus Biosciences files for offering of up to $6.9 mln shares - SEC filing

* Files for offering of up to $6.9 million of co's common stock - SEC filing Source text: (http://bit.ly/2nAN3OB) Further company coverage:

BRIEF-Apricus Biosciences announces sale of ex-U.S. Vitaros assets, rights to Ferring Pharmaceuticals

* Apricus biosciences announces sale of ex-u.s. Vitaros assets and rights to ferring pharmaceuticals

BRIEF-Apricus Biosciences announces approval of Vitaros

* Apricus Biosciences announces approval of vitaros for the treatment of erectile dysfunction in Mexico

BRIEF-Apricus intends to re-submit Vitaros NDA as soon as possible in 2017

* Received feedback in response to its previously announced Type B meeting request to U.S. Food and Drug Administration

BRIEF-Apricus Biosciences posts Q3 loss per share $0.19

* Apricus Biosciences provides corporate update and third quarter financial results

Select another date:

More From Around the Web